Oncolytics Biotech (ONCY) EPS (Basic) (2009 - 2026)
Oncolytics Biotech (ONCY) posted quarterly EPS (Basic) of -$0.11 for Q3 2025, down 17.98% year-over-year from -$0.13 in Q3 2024, and down 97.04% quarter-over-quarter from -$0.05 in Q2 2025.
Oncolytics Biotech (ONCY) EPS (Basic) (2009 - 2026) Analysis & Trends
Oncolytics Biotech (ONCY) has reported EPS (Basic) for 17 consecutive years, with -$0.11 the latest figure, recorded in Q3 2025.
- In Q3 2025, EPS (Basic) fell 17.98% year-over-year to -$0.11; the TTM figure through Dec 2025 stood at -$0.16 (up 30.29% YoY), while the FY2025 annual figure was -$0.3, changed 0.11% from the prior year.
- EPS (Basic) retreated to -$0.11 in Q3 2025 per ONCY's latest filing, from -$0.05 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.11 in Q2 2021 and bottomed at -$0.67 in Q4 2021.
- Historically, EPS (Basic) has averaged -$0.12 across 5 years, with a median of -$0.07 in 2024.
- On a YoY basis, EPS (Basic) climbed as much as 186.01% in 2021 and fell as far as 198.19% in 2021.
- Oncolytics Biotech's EPS (Basic) stood at -$0.67 in 2021, then increased by 22.52% to -$0.52 in 2022, then fell by 8.26% to -$0.56 in 2023, then jumped by 86.64% to -$0.07 in 2024, then sank by 43.28% to -$0.11 in 2025.
- Business Quant data shows ONCY's EPS (Basic) at -$0.11 in Q3 2025, -$0.05 in Q2 2025, and -$0.07 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Oncolytics Biotech | 96.23 Mn | 96.23 Mn | - | -0.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.10 |
| Sep 30, 2025 | -0.11 |
| Jun 30, 2025 | -0.05 |
| Dec 31, 2024 | -0.07 |
| Sep 30, 2024 | -0.09 |
| Jun 30, 2024 | -0.07 |
| Dec 31, 2023 | -0.56 |
| Sep 30, 2023 | -0.10 |
| Jun 30, 2023 | -0.09 |
| Mar 31, 2023 | 0.08 |
| Dec 31, 2022 | -0.52 |
| Sep 30, 2022 | -0.05 |
| Jun 30, 2022 | -0.07 |
| Mar 31, 2022 | 0.10 |
| Dec 31, 2021 | -0.67 |
| Sep 30, 2021 | 0.07 |
| Jun 30, 2021 | 0.11 |
| Mar 31, 2021 | 0.10 |
| Dec 31, 2020 | 0.68 |
| Sep 30, 2020 | -0.12 |